This week’s RA/QA news roll is live, and it’s a heavy one.

FDA leadership turmoil continues. Vaccine policy shifts are accelerating. QMSR technical amendments are finalized ahead of February 2026. AI use at FDA is expanding beyond LLMs into agentic systems. And enforcement actions keep surfacing the same GMP and QSR failures.

Much more for paid subscribers.